feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Verstappen wins Qatar Grand Prix

trending

Kyren Williams injury update

trending

College Football AP Poll rankings

trending

Panthers beat Rams, end streak

trending

Updated NFC standings for Week

trending

Jaguars chase AFC South title

trending

Trevor Lawrence leads Jaguars victory

trending

Aaron Rodgers' wrist fractures revealed

trending

Jayden Daniels elbow injury

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Technology / AI Not an Inventor, But a Tool, USPTO Rules

AI Not an Inventor, But a Tool, USPTO Rules

28 Nov

•

Summary

  • Generative AI cannot be named as an inventor under US patent law.
  • USPTO views AI as a tool, similar to software or lab equipment.
  • Traditional joint inventorship principles still apply with AI assistance.
AI Not an Inventor, But a Tool, USPTO Rules

The US Patent and Trademark Office (USPTO) has issued updated guidelines regarding the use of generative AI in the innovation process. According to USPTO Director John Squires, AI systems, including generative AI, are viewed as instruments employed by human inventors. These systems are comparable to other tools such as research databases or laboratory equipment, which aid in the conception and development of inventions.

Despite AI's capability to generate ideas and provide services, the USPTO maintains that only natural persons can be recognized as inventors. This stance aligns with previous rulings by the Court of Appeals for the Federal Circuit, which established that AI cannot be named on patent applications or issued patents. The new guidelines do not alter this fundamental principle.

Furthermore, the USPTO has confirmed that no distinct evaluation process exists for AI-assisted inventions. When multiple individuals contribute to an invention with AI's help, standard joint inventorship principles will continue to be applied. This clarification aims to provide greater certainty for patenting innovations developed with the assistance of advanced AI technologies.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
No, the US Patent and Trademark Office (USPTO) has clarified that generative AI cannot be named as an inventor under US patent laws. Only natural persons can be inventors.
The USPTO views generative AI as an analogous tool, similar to software or research databases, used by human inventors in the creation process.
Traditional joint inventorship principles apply when AI assistance is involved in creating an invention. The human inventor who conceived the invention remains central.

Read more news on

Technologyside-arrow

You may also like

Philip Morris Stock: Smoke-Free Push Fuels Growth

29 Nov • 6 reads

article image

Furniture Giant Files Bankruptcy Amid Housing Slump

25 Nov • 7 reads

article image

Trade Desk Stock Plunges 64% Despite Tech Boom, Analysts See 50% Upside

18 Nov • 47 reads

article image

FDA Eases Biosimilar Approvals, but Patent Hurdles Remain

14 Nov • 72 reads

article image

Regis Industries Profits Plummet 20% Amid 86% Sales Decline

14 Nov • 11 reads